Heartland Research Associates, LLC
1709 S Rock Rd
Wichita, Kansas 67207
316-689-6629 http://www.heartlandresearch.com kstoddard@heartlandresearch.com

Use our guide to learn which trials are right for you!

HRA believes that the progress made in research today will give us hope and assurance of a tomorrow. HRA originally began as a department of Family Medicine East, the owners developed this highly successful department into its own LLC in 1991. Located within the heartland of the U.S., HRA is now a dedicated, independent clinical research site, specializing in providing Phase I inpatient and outpatient through phase V clinical research services for pharmaceutical, nutritional and medical device industries. HRA's main site is located in east Wichita, Kansas, with 3 satellite sites in west Wichita, Arkansas City, Newton and Augusta, Kansas. HRA's mission is to provide quality medical care to their research participants, with a commitment to accurate and precise data for their sponsors. The resulting strong relationship with their patients aids in successful recruitment, compliance, and retention.

HRA has conducted more than 875 national and multinational clinical trials in the therapeutic areas of: Dermatology, Device, Endocrinology, Gastroenterology, Genotyping, Infectious Disease, Male Health & Erectile Dysfunction, Musculoskeletal & Connective Tissue Disorders, Neurology, Ophthalmology, Otolaryngology, Pain Management, Pediatrics, Pulmonology/Critical Care, Respiratory, Urology/Nephrology, Vascular/Cardiovascular Disorders, Weight Loss and Women's Health.

Some of the sponsors and CRO Heartland has worked with include: 3M, Abbott, Acer/Excel, Advanced Biologics, Agouron, Alcon, Almirall Prodesfarma, Astra Merck Astra Zeneca, Aventis, BARR, Bayer, Bio Cryst, Boehringer Ingelheim, BMS, Cellegy, Centocor, Chiesi, ClinTrials, CIBA, Covance, DepoMed, Eisai, Eli Lilly, Endo Pharm., Genaissance, Genentech, Genomics, Glaxo Wellcome, GSK, Hisamitsu, HumaScan, i3 Research, ICON, Insight Vision, Janssen, Kendle, KOS, KV Pharm., MDS Pharma, Merck, McNeil, Novo Nordisk, Novartis, Omnicare, Organon, OrthoMcNeil, Otsuka, Paragon, Parke-Davis, Pfizer, Pharmacia, Phoenix, Praecis, Proctor & Gamble, Purdue, Quintiles, Regeneron, Reliant, Resource Solutions, Roche, Ross/Abbott, RWJ, Sandoz, Sankyo, Schering Plough, Searle, Sepracor, SKB, Sucampo, Takeda, TAP, Target, VELA, ViroPharma, Winston Labs, WyethAyerst.

Terry L. Poling, MD, DABFP, FAAFP, CCPI is board-certified in Family Practice and is a co-founder of HRA. Dr. Poling is an AMA delegate for Kansas, acts as Chairman and Medical Director for the Wichita Preferred Provider Association, and is a Past-President for the Kansas Medical Society. Additionally, Dr. Poling is a Clinical Assistant Professor at the University of Kansas School of Medicine.

Dr. Terry D. Klein, MD, DABFP, CCPI is board-certified in Family Practice and is a co-founder of HRA. Dr. Klein is a Clinical Assistant Professor at the University of Kansas School of Medicine. Additionally, Dr. Klein is a President of an IPA, and is a Past President for the Kansas Medical Society and currently holds a board position.

Dr. Thomas Klein MD, DABFP, CCPI is board-certified in Family Practice and is a co-founder of HRA. Dr. Klein is a Clinical Assistant Professor at the University of Kansas School of Medicine. Additionally, Dr. Klein is certified for full privileges in EGD's, fiber optic sigmoidoscopy and colonoscopy.

Dr. Scott L. Meyers, MD, DABFP, CCPI is board-certified in Family Practice. Dr. Meyers has served as MSSC delegate to the Kansas Medical Society and is currently serving a position on the insurance committee for the County Medical Society. Additionally, Dr. Meyers serves as a Clinical Instructor at the University of Kansas School of Medicine.

Dr. Tracy R. Klein, MD, DABFP, CCPI is board-certified in Family Practice. Dr. Klein is CDE eligible, and is actively involved with an affiliated organization, Heartland Diabetes Associates, LLC.

HRA's Medical Management has an average of over 9 years in Research. HRA also has over 30 board-certified affiliated physicians.

The staff at HRA has over 100 years of cumulative research experience. HRA currently staffs 18 full-time Clinical Research Coordinators - many being CCRC's. There are 10 Research Assistants, 7 Patient Referral Specialists, 2 Regulatory Specialists, 2 Receptionists, 4 Quality Assurance staff, a Source Writer as well as a Financial Specialist, all of whom work diligently to provide care for both patients and sponsors. HRA also has 3 Trained Alzheimer's Rating Specialists, 2 Smoking Cessation Counselors and a contract Registered Dietician. HRA has implemented a Quality Assurance Department in 2007 to ensure the quality and accuracy of its research.


Advertising is done through the television, newspaper, direct mail, website and radio medias. Patients are also drawn from an internal extensive database of over 85,000 patients. Community physicians and study participants have also referred many patients. HRA also has access to affiliated physician databases. This all contributes to HRA's enrollment success of >114%, with a low screen failure rate and high enrollment, with a patient population ranging from pediatrics to geriatrics. Heartland Diabetes Association, LLC, aides in HRA's ability to recruit patients by providing access to more than 1000 active diabetic patients and by employing a knowledgeable diabetic staff, including a Certified Diabetic Educator. The Medical Management Directors are Recognized Providers by ADA and NCQA - the only family practice physicians in Kansas to hold this distinction.


Cardiology/Vascular Diseases
Dental/Maxillofacial Surgery
Dermatology/Plastic Surgery
Endocrinology
Gastroenterology
Immunology/Infectious Diseases
Musculoskeletal
Nephrology/Urology
Neurology
Obstetrics/Gynecology
Ophthalmology
Otolaryngology
Pediatrics/Neonatology
Psychiatry/Psychology
Pulmonary/Respiratory Diseases
Rheumatology

HRA's main office is located in the same facility as Family Medicine East, but is a distinctly separate entity and maintains over 3,400 square feet of the 16, 580 square foot building, additionally HRA owns the 2,912 square foot building next door. HRA has, or has access to: Radiology, Densitometry, Uroflow Machine, Sahar extremity densitometry, refrigerated centrifuge, EKG machines, EGD, sigmoid and colonoscopy services, -20° and -70° freezers, ambulatory blood pressure monitoring, registered dietician, CLIA/OSHA Certified Lab & Phlebotomy, Spirometry, Pollen Counting, Colposcopy L.E.E.P, Certified Smoking Cessation Counselors and a Pulse Oximetry. The main office also has 6 dedicated exam rooms, while each of the satellite offices has a minimum of 1 dedicated exam room. Each office has a general storage facility, dedicated monitor room/s with high speed cable internet connections, locked study drug closet or cabinet and conference rooms for site/ initiation visits. Each facility is also HIPPA compliant and there are IATA/FAA certified staff for the shipment of hazardous materials.

Each office is located near hotels and easy driving distance from the airport with easy highway accessibility. There are many attractions, museums and fine dining restaurants in the area for those spending extra time in at any of the offices.


Kathy Stoddard
Clinical Research Director
Heartland Research Associates, LLC
East Office
1709 S Rock Rd
Wichita, KS 67207
USA
316-689-6629
316-689-6690 (fax)
kstoddard@heartlandresearch.com
www.heartlandresearch.com


We've found
27 trials
at this facility
Alzheimer's Disease Clinical Trial
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
Status: Enrolling, Phase III
Updated: 3/25/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Evaluation of LY2951742 in the Prevention of Chronic Migraine
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Osteoarthritis Clinical Trial
Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
Status: Enrolling, Phase III
Updated: 3/16/2017
mi
from
Wichita, KS
Click here to add this to my saved trials
Contraception Clinical Trial
Study of the Contraceptive Efficacy and Safety of Amphora Gel Compared to Conceptrol Vaginal Gel
Status: Enrolling
Updated: 10/26/2012
mi
from
Wichita, KS
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Neurology Clinical Trial
Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)
Status: Enrolling
Updated: 3/15/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
mi
from
Wichita, KS
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
Status: Enrolling, Phase III
Updated: 2/19/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Smoking Cessation Clinical Trial
Smoking Cessation Study In Healthy Adolescent Smokers
Status: Enrolling, Phase IV
Updated: 3/23/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Growth Clinical Trial
Growth and Tolerance of Cow's Milk-Based Infant Formulas
Status: Enrolling
Updated: 7/9/2015
mi
from
Wichita, KS
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Lupus Clinical Trial
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
Status: Enrolling, Phase II
Updated: 3/28/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Musculoskeletal, Rheumatology Clinical Trial
Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
Status: Enrolling, Phase III
Updated: 4/6/2017
mi
from
Wichita, KS
Click here to add this to my saved trials
Endocrinology Clinical Trial
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
Status: Enrolling
Updated: 10/22/2012
mi
from
Wichita, KS
Click here to add this to my saved trials
Constipation - Functional Clinical Trial
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling, Phase III
Updated: 2/29/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Migraine Clinical Trial
Evaluation of LY2951742 in the Prevention of Episodic Migraine- the EVOLVE-2 Study
Status: Enrolling, Phase III
Updated: 3/9/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 2/22/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Diabetes Type 2 Clinical Trial
Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Status: Enrolling, Phase II
Updated: 2/1/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Status: Enrolling, Phase III
Updated: 3/29/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
Status: Enrolling, Phase III
Updated: 3/30/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Status: Enrolling, Phase IV
Updated: 3/12/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Osteoarthritis Clinical Trial
Study of Meloxicam Capsules to Treat Osteoarthritis Pain
Status: Enrolling
Updated: 3/7/2013
mi
from
Wichita, KS
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Status: Enrolling, Phase III
Updated: 3/25/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Primary Hypertension Clinical Trial
A Study of LY2623091 in Participants With High Blood Pressure
Status: Enrolling, Phase II
Updated: 10/10/2014
mi
from
Wichita, KS
Click here to add this to my saved trials
Influenza Clinical Trial
Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age
Status: Enrolling, Phase III
Updated: 11/4/2014
mi
from
Wichita, KS
Click here to add this to my saved trials
Smallpox Clinical Trial
A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
Status: Enrolling, Phase III
Updated: 11/30/2015
mi
from
Wichita, KS
Click here to add this to my saved trials
Overactive Bladder Clinical Trial
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Status: Enrolling
Updated: 10/31/2012
mi
from
Wichita, KS
Click here to add this to my saved trials